Search

Amit Kokate

from Rockville, MD
Age ~44
Get Report
Related to:
Kunal A Kokate, 24Ashwini S Kokate, 69Agnesh Kokate, 57Ashwini S KokateSarika Kokate, 29Chandrakant Kokate, 77Tushar G Kokate, 62Shirish G Kokate, 57
Connected to:
Gauri J Kokate, 52Prabhakar A Kokate, 66Anne H Kokawa, 73Naoki Kokawa, 48John C Kokay, 29Mariaolga KokaychukWilliam Koke, 84Richard W Kokel, 69Kelley M Kokemiller, 55Deann M Kokemohr, 43

Amit Kokate Phones & Addresses

  • 11908 Bristol Manor Ct, Rockville, MD 20852
  • N Bethesda, MD
  • Fort Lee, NJ
  • Englewood, NJ
  • Bedminster, NJ
  • Nanuet, NY
  • Oakland, NJ
  • Chandler, AZ
  • Stockton, CA

Publications

Us Patents

Liquid Cannabinoid Formulations

View page
US Patent:
20110306660, Dec 15, 2011
Filed:
Aug 31, 2011
Appl. No.:
13/222989
Inventors:
Venkat R. Goskonda - Phoenix AZ, US
Ashok Chavan - Chandler AZ, US
Amit Kokate - Englewood NJ, US
Howard Gill - Scottsdale AZ, US
International Classification:
A61K 31/352
A61P 1/08
US Classification:
514454
Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.

Oral Cannabinoid Formulations

View page
US Patent:
20190192428, Jun 27, 2019
Filed:
Feb 22, 2019
Appl. No.:
16/282817
Inventors:
- Chandler AZ, US
Ashok Chavan - Chandler AZ, US
Amit Kokate - Englewood NJ, US
Howard Gill - Scottsdale, GB
International Classification:
A61K 9/00
A61K 31/353
A61K 47/10
A61K 9/08
A61K 9/48
Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.

Oral Cannabinoid Formulations

View page
US Patent:
20160228405, Aug 11, 2016
Filed:
Apr 19, 2016
Appl. No.:
15/132896
Inventors:
- Chandler AZ, US
Ashok Chavan - Chandler AZ, US
Amit Kokate - Englewood NJ, US
Howard Gill - , US
International Classification:
A61K 31/352
A61K 36/185
A61K 9/08
Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.

Oral Cannabinoid Formulations

View page
US Patent:
20140100269, Apr 10, 2014
Filed:
Oct 4, 2012
Appl. No.:
13/644283
Inventors:
- Phoenix AZ, US
Ashok Chavan - Chandler AZ, US
Amit Kokate - Englewood NJ, US
Howard Gill - Scottsdale AZ, US
Assignee:
INSYS THERAPEUTICS, INC. - Phoenix AZ
International Classification:
A61K 47/10
US Classification:
514454
Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
Control profile
Amit Kokate from Rockville, MD, age ~44 Get Report